Additionally, Phenibut is highly addictive and can cause severe withdraw syptoms including votiting, heart attacks, and other major health related issues if a consumer suddenly stops taking it after growing dependent on it.
[pdf-embedder url=”https://usaherald.com/wp-content/uploads/2021/04/Evol-Complaint.pdf” title=”Evol Complaint”]
FDA Warning
In April 2019, the U.S. Food and Drug Administration (FDA) notified Evol Nutrition against their products’ use of Phenibut.
The class action lawsuit states that FDA informed the company that their health supplements were mislabeled because it did not indicate that they contained Phenibut.
It did not properly notify customers about the possible side effects.
It adds that the use of Phenibut in products is also being investigated in Austria, Hungary, Italy, and Lithuania because of overdose and withdrawal reports from individuals who consumed it.
Plaintiff Allegations
The lead plaintiff argues that Evol Nutrition has falsely marketed the alleged products as safe health supplements.
